NEWS & PRESS
Featured News
12.2021 / Press release
Eligo announces successful outcome in US CRISPR patent interference against SNIPR Biome
02.2022 / Article in Microbiome Times
ELIGO v SNIPR: a reflection on IP strategies in a competitive environment
05.2022 / Article in Biocentury
CRISPR’s other patent interference
Featured Press & Media
All News & Press
11.2022 / Press release
Key patent issued on Eligo’s gene editing breakthroughs applied to skin disorders
10.2022 / Press release
Eligo Bioscience Receives FDA Orphan Drug Designation (ODD) and Rare Pediatric Disease (RPD) Designation with First-in-class CRISPR-based medicine
09.2022 / Press release
Eligo Bioscience and Kantonsspital St. Gallen announce their strategic alliance to address inflammatory cardiac diseases through in vivo gene editing
06.2022 / Press release
Eligo unlocks next generation of precision genetic medicine with foundational patents granted covering in-situ base editing of the microbiome and presents first-ever animal data at CRISPR 2022 Conference
06.2021 / Press release
Eligo Presents Preclinical Data Demonstrating for the First Time that Gut Microbiome Modulation via Delivery of CRISPR Nuclease Impacts Disease Progression
03.2021 / Press release
Eligo Bioscience strengthens leadership with the appointment of former GSK R&D Executive, Dr. Hessel, as Chief Scientific Officer
06.2020 / Press release
CARB-X funds Eligo Bioscience to develop CRISPR-based therapeutics derived from bacteriophages to kill superbugs and prevent deadly infections in transplant patients
09.2019 / Press release
Eligo Bioscience strengthens its leadership and development team
More →
05.2019 / Press release
Eligo has been selected by the European Commission as one of the top 1% Science Startups in Europe and received a €2.8M grant for the development of their lead candidate
More →
02.2019 / La Tribune
Eligo’s CEO is listed among the 100 influencers that will are transforming the French economy
More →
10.2018 / Les Echos
Eligo is listed among the 10 French startups shaping the future of Healthcare
04.2018 / French Government
Eligo is a laureate of the Worldwide Innovation Challenge and grabs €1.8M in non-dilutive funding
More →
09.2017 / Press release, TechCrunch, Business Insider, Les Echos, Le Monde, WSJ…
Eligo secures $20M round of funding from Khosla Ventures & Seventure
More →
06.2017 / World Economic Forum
Eligo is selected as a 2017 Technology Pioneer by the World Economic Forum
More →
01.2017 / Forbes
Xavier Duportet, Eligo’s CEO, is selected among the Forbes 30 Under 30 Europe in Science & Healthcare
More →
09.2016 / Agence Nationale de la Recherche
Eligo Bioscience is awarded two highly-selective grants by the French National Research Agency
More →
05.2016 / Press Release
JP Lehner, former Chief Medical Officer at Sanofi, joins Eligo Bioscience’s Board of Directors
More →
07.2015 / Press Release
Eligo closes a €2M seed-funding round with Seventure Partners
More →
02.2015 / Tremplin Entreprises
Eligo is a laureate of the Tremplin Entreprises National Startup Competition
More →
